Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Diabetology & Metabolic Syndrome
Published in: Diabetology & Metabolic Syndrome 1/2024

Open Access 01-12-2024 | Atrial Fibrillation | Research

Increased susceptibility to new-onset atrial fibrillation in diabetic women with poor sleep behaviour traits: findings from the prospective cohort study in the UK Biobank

Authors: Siwei Chen, Zhou Liu, Shaohua Yan, Zhongyan Du, Wenke Cheng

Published in: Diabetology & Metabolic Syndrome | Issue 1/2024

Login to get access

Abstract

Background

Diabetic individuals often encounter various sleep-related challenges. Although the association between sleep duration and atrial fibrillation (AF) have been explored, the association of other sleep traits with the incidence of AF remains unclear. A comprehensive understanding of these traits is essential for a more accurate assessment of sleep conditions in patients with diabetes and the development of novel AF prevention strategies.

Methods

This study involved 23,785 patients with diabetes without any pre-existing cardiovascular disease, drawn from the UK Biobank. Sleep behaviour traits examined encompassed sleep duration, chronotype, insomnia, snoring and daytime sleepiness. Sleep duration was categorised into three groups: low (≤ 5 h), proper (6–8 h) and long (≥ 9 h). We assessed associations using multivariate Cox proportional risk regression models. Furthermore, four poor sleep behaviours were constructed to evaluate their impact on the risk of new-onset AF.

Results

Over a mean follow-up period of 166 months, 2221 (9.3%) new cases of AF were identified. Short (hazard ratio (HR), 1.28; 95% confidence interval (CI) 1.10–1.50) and long sleep durations (HR 1.16; 95% CI 1.03–1.32) consistently exhibited an elevated risk of AF compared to optimal sleep duration. Early chronotype, infrequent insomnia and daytime sleepiness were associated with 11% (HR 0.89; 95% CI 0.82–0.97), 15% (HR 0.85; 95% CI 0.77–0.95) and 12% (HR 0.88; 95% CI 0.81–0.96) reduced risk of new-onset AF, respectively. However, no significant association was found between snoring and the incidence of AF (HR 0.99; 95% CI 0.91–1.07).

Conclusions

In diabetic populations, sleep duration, chronotype, insomnia and daytime sleepiness are strongly associated with AF incidence. An optimal sleep duration of 6–8 h presents the lowest AF risk compared to short or long sleep duration. Additionally, poor sleep patterns present a greater risk of new-onset AF in women than in men.
Appendix
Available only for authorised users
Literature
1.
Cho JW, Duffy JF. Sleep, sleep disorders, and sexual dysfunction. World J Mens Health. 2019;37:261–75.PubMedCrossRef
2.
3.
4.
5.
Tobaldini E, Costantino G, Solbiati M, Cogliati C, Kara T, Nobili L, Montano N. Sleep, sleep deprivation, autonomic nervous system and cardiovascular diseases. Neurosci Biobehav Rev. 2017;74:321–9.PubMedCrossRef
6.
Mullington JM, Haack M, Toth M, Serrador JM, Meier-Ewert HK. Cardiovascular, inflammatory, and metabolic consequences of sleep deprivation. Prog Cardiovasc Dis. 2009;51:294–302.PubMedPubMedCentralCrossRef
7.
Miller MA, Cappuccio FP. Inflammation, sleep, obesity and cardiovascular disease. Curr Vasc Pharmacol. 2007;5:93–102.PubMedCrossRef
8.
Elliott AD, Middeldorp ME, van Gelder IC, Albert CM, Sanders P. Epidemiology and modifiable risk factors for atrial fibrillation. Nat Rev Cardiol. 2023;20:404–17.PubMedCrossRef
9.
Lippi G, Sanchis-Gomar F, Cervellin G. Global epidemiology of atrial fibrillation: an increasing epidemic and public health challenge. Int J Stroke. 2021;16:217–21.PubMedCrossRef
10.
Ong KL, Stafford LK, McLaughlin SA, Boyko EJ, Vollset SE, Smith AE, Dalton BE, Duprey J, Cruz JA, Hagins H, Lindstedt PA. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet. 2023;402:203–34.CrossRef
11.
12.
13.
Wang C, Bangdiwala SI, Rangarajan S, Lear SA, AlHabib KF, Mohan V, Teo K, Poirier P, Tse LA, Liu Z, Rosengren A, Kumar R, Lopez-Jaramillo P, Yusoff K, Monsef N, Krishnapillai V, Ismail N, Seron P, Dans AL, Kruger L, Yeates K, Leach L, Yusuf R, Orlandini A, Wolyniec M, Bahonar A, Mohan I, Khatib R, Temizhan A, Li W, Yusuf S. Association of estimated sleep duration and naps with mortality and cardiovascular events: a study of 116 632 people from 21 countries. Eur Heart J. 2019;40:1620–9.PubMedCrossRef
14.
Wang D, Li W, Cui X, Meng Y, Zhou M, Xiao L, Ma J, Yi G, Chen W. Sleep duration and risk of coronary heart disease: a systematic review and meta-analysis of prospective cohort studies. Int J Cardiol. 2016;219:231–9.PubMedCrossRef
15.
Kwok CS, Kontopantelis E, Kuligowski G, Gray M, Muhyaldeen A, Gale CP, Peat GM, Cleator J, Chew-Graham C, Loke YK, Mamas MA. Self-reported sleep duration and quality and cardiovascular disease and mortality: a dose-response meta-analysis. J Am Heart Assoc. 2018;7: e008552.PubMedPubMedCentralCrossRef
16.
Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J, Downey P, Elliott P, Green J, Landray M, Liu B, Matthews P, Ong G, Pell J, Silman A, Young A, Sprosen T, Peakman T, Collins R. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015;12: e1001779.PubMedPubMedCentralCrossRef
17.
Elliott P, Peakman TC. The UK Biobank sample handling and storage protocol for the collection, processing and archiving of human blood and urine. Int J Epidemiol. 2008;37:234–44.PubMedCrossRef
18.
Chen RW, Ulsa MC, Li P, Gao C, Zheng X, Xu J, Luo Y, Shen S, Lane J, Scheer, Frank A J L, Hu K, Gao L (2023) Sleep behavior traits and associations with opioid-related adverse events: a cohort study. Sleep 46:zsad118
19.
American Diabetes Association Professional Practice Committee, American Diabetes Association Professional Practice Committee. 2. Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes—2022. Diabetes care. 2022;45(Supplement_1):S17–38.
20.
Yousaf S, Bonsall A. UK Townsend Deprivation Scores from 2011 census data. Colchester, UK: UK Data Service, 2017.
21.
Liao Y, Zhang R, Shi S, Zhao Y, He Y, Liao L, Lin X, Guo Q, Wang Y, Chen L, Li W, Li S, Chen K, Fang Y. Triglyceride-glucose index linked to all-cause mortality in critically ill patients: a cohort of 3026 patients. Cardiovasc Diabetol. 2022;21:128.PubMedPubMedCentralCrossRef
22.
Park S-Y, Freedman ND, Haiman CA, Le Marchand L, Wilkens LR, Setiawan VW. Association of coffee consumption with total and cause-specific mortality among nonwhite populations. Ann Intern Med. 2017;167:228–35.PubMedPubMedCentralCrossRef
23.
de Wreede LC, Fiocco M, Putter H. The Mstate package for estimation and prediction in non- and semi-parametric multi-state and competing risks models. Comput Methods Programs Biomed. 2010;99:261–74.PubMedCrossRef
24.
Arafa A, Kokubo Y, Shimamoto K, Kashima R, Watanabe E, Sakai Y, Li J, Teramoto M, Sheerah HA, Kusano K. Sleep duration and atrial fibrillation risk in the context of predictive, preventive, and personalized medicine: the Suita Study and meta-analysis of prospective cohort studies. EPMA J. 2022;13:77–86.PubMedPubMedCentralCrossRef
25.
Morovatdar N, Ebrahimi N, Rezaee R, Poorzand H, Bayat Tork MA, Sahebkar A. Sleep duration and risk of atrial fibrillation: a systematic review. J Atr Fibrillation. 2019;11:2132.PubMedPubMedCentral
26.
Zhao J, Yang F, Zhuo C, Wang Q, Qu Z, Wang Q, Zheng L. Association of sleep duration with atrial fibrillation and heart failure: a Mendelian randomization analysis. Front Genet. 2021;12: 583658.PubMedPubMedCentralCrossRef
27.
Ai S, Zhang J, Zhao G, Wang N, Li G, So H-C, Liu Y, Chau SW-H, Chen J, Tan X, Jia F, Tang X, Shi J, Lu L, Wing Y-K. Causal associations of short and long sleep durations with 12 cardiovascular diseases: linear and nonlinear Mendelian randomization analyses in UK Biobank. Eur Heart J. 2021;42:3349–57.PubMedCrossRef
28.
29.
Williams CJ, Hu FB, Patel SR, Mantzoros CS. Sleep duration and snoring in relation to biomarkers of cardiovascular disease risk among women with type 2 diabetes. Diabetes Care. 2007;30:1233–40.PubMedCrossRef
30.
Yoshioka E, Saijo Y, Kita T, Okada E, Satoh H, Kawaharada M, Kishi R. Relation between self-reported sleep duration and arterial stiffness: a cross-sectional study of middle-aged Japanese civil servants. Sleep. 2011;34:1681–6.PubMedPubMedCentralCrossRef
31.
Nagai M, Hoshide S, Ishikawa J, Shimada K, Kario K. Visit-to-visit blood pressure variations: new independent determinants for carotid artery measures in the elderly at high risk of cardiovascular disease. J Am Soc Hypertens. 2011;5:184–92.PubMedCrossRef
32.
Rothwell PM, Howard SC, Dolan E, O’Brien E, Dobson JE, Dahlöf B, Sever PS, Poulter NR. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet. 2010;375:895–905.PubMedCrossRef
33.
Johansson JK, Kronholm E, Jula AM. Variability in home-measured blood pressure and heart rate: associations with self-reported insomnia and sleep duration. J Hypertens. 2011;29:1897–905.PubMedCrossRef
34.
Wong PM, Hasler BP, Kamarck TW, Muldoon MF, Manuck SB. Social jetlag, chronotype, and cardiometabolic risk. J Clin Endocrinol Metab. 2015;100:4612–20.PubMedPubMedCentralCrossRef
35.
Hsu C-Y, Chen Y-T, Chen M-H, Huang C-C, Chiang C-H, Huang P-H, Chen J-W, Chen T-J, Lin S-J, Leu H-B, Chan W-L. The association between insomnia and increased future cardiovascular events: a nationwide population-based study. Psychosom Med. 2015;77:743–51.PubMedCrossRef
36.
Li M, Li K, Zhang X-W, Hou W-S, Tang Z-Y. Habitual snoring and risk of stroke: a meta-analysis of prospective studies, Netherlands. 2015.
37.
Boden-Albala B, Roberts ET, Bazil C, Moon Y, Elkind MSV, Rundek T, Paik MC, Sacco RL. Daytime sleepiness and risk of stroke and vascular disease: findings from the Northern Manhattan Study (NOMAS). Circ Cardiovasc Qual Outcomes. 2012;5:500–7.PubMedPubMedCentralCrossRef
38.
39.
Merikanto I, Lahti T, Puolijoki H, Vanhala M, Peltonen M, Laatikainen T, Vartiainen E, Salomaa V, Kronholm E, Partonen T. Associations of chronotype and sleep with cardiovascular diseases and type 2 diabetes. Chronobiol Int. 2013;30:470–7.PubMedCrossRef
40.
Lee H-H, Chen Y-C, Chen J-J, Lo S-H, Guo Y-L, Hu H-Y. Insomnia and the risk of atrial fibrillation: a population-based cohort study. Acta Cardiol Sin. 2017;33:165–72.PubMedPubMedCentral
41.
Han X, Yang Y, Chen Y, Gao L, Yin X, Li H, Qiu J, Wang Y, Zhou Y, Xia Y. Association between insomnia and atrial fibrillation in a Chinese population: a cross-sectional study. Clin Cardiol. 2017;40:765–9.PubMedPubMedCentralCrossRef
42.
Wu TT, Zou YL, Xu KD, Jiang XR, Zhou MM, Zhang SB, Song CH. Insomnia and multiple health outcomes: umbrella review of meta-analyses of prospective cohort studies. Public Health. 2023;215:66–74.PubMedCrossRef
43.
Liu X, Li C, Sun X, Yu Y, Si S, Hou L, Yan R, Yu Y, Li M, Li H, Xue F. Genetically predicted insomnia in relation to 14 cardiovascular conditions and 17 cardiometabolic risk factors: a Mendelian randomization study. J Am Heart Assoc. 2021;10: e020187.PubMedPubMedCentralCrossRef
44.
Cang J, Shi N, Zhu D, Liu Y, Zhou Q, Chen L. Self-reported sleep pattern and recurrence of atrial fibrillation after catheter ablation. Clin Cardiol. 2023;46:336–44.PubMedPubMedCentralCrossRef
45.
Lin G-M, Colangelo LA, Lloyd-Jones DM, Redline S, Yeboah J, Heckbert SR, Nazarian S, Alonso A, Bluemke DA, Punjabi NM, Szklo M, Liu K. Association of sleep apnea and snoring with incident atrial fibrillation in the multi-ethnic study of atherosclerosis. Am J Epidemiol. 2015;182:49–57.PubMedPubMedCentralCrossRef
46.
Mahmood K, Akhter N, Eldeirawi K, Onal E, Christman JW, Carley DW, Herdegen JJ. Prevalence of type 2 diabetes in patients with obstructive sleep apnea in a multi-ethnic sample. J Clin Sleep Med. 2009;5:215–21.PubMedPubMedCentralCrossRef
47.
Serednytskyy O, Alonso-Fernández A, Ribot C, Herranz A, Álvarez A, Sánchez A, Rodríguez P, Gil AV, Pía C, Cubero JP, Barceló M, Cerdà M, Codina M, Peña D. Systemic inflammation and sympathetic activation in gestational diabetes mellitus with obstructive sleep apnea. BMC Pulm Med. 2022;22:94.PubMedPubMedCentralCrossRef
48.
Al Oweidat K, Toubasi AA, Al-Sayegh TN, Sinan RA, Mansour SH, Makhamreh HK. Cardiovascular diseases across OSA phenotypes: A retrospective cohort study. Sleep Med X. 2023;6: 100090.PubMedPubMedCentralCrossRef
49.
Carrier J, Semba K, Deurveilher S, Drogos L, Cyr-Cronier J, Lord C, Sekerovick Z. Sex differences in age-related changes in the sleep-wake cycle. Front Neuroendocrinol. 2017;47:66–85.PubMedCrossRef
50.
Dib R, Gervais NJ, Mongrain V. A review of the current state of knowledge on sex differences in sleep and circadian phenotypes in rodents. Neurobiol Sleep Circadian Rhythms. 2021;11: 100068.PubMedPubMedCentralCrossRef
51.
Duffy JF, Cain SW, Chang A-M, Phillips AJK, Münch MY, Gronfier C, Wyatt JK, Dijk D-J, Wright KP. Sex difference in the near-24-hour intrinsic period of the human circadian timing system. Proc Natl Acad Sci U S A. 2011;108(Suppl 3):15602–8.PubMedPubMedCentralCrossRef
52.
Cain SW, Dennison CF, Zeitzer JM, Guzik AM, Khalsa SBS, Santhi N, Schoen MW, Czeisler CA, Duffy JF. Sex differences in phase angle of entrainment and melatonin amplitude in humans. J Biol Rhythms. 2010;25:288–96.PubMedPubMedCentralCrossRef
53.
Cappuccio FP, Stranges S, Kandala N-B, Miller MA, Taggart FM, Kumari M, Ferrie JE, Shipley MJ, Brunner EJ, Marmot MG. Gender-specific associations of short sleep duration with prevalent and incident hypertension: the Whitehall II Study. Hypertension. 2007;50:693–700.PubMedCrossRef
54.
Guo M, Feng T, Liu M, Hua Z, Ma Y, Cai J-P, Li X-J. Causal roles of daytime sleepiness in cardiometabolic diseases and osteoporosis. Eur Rev Med Pharmacol Sci. 2022;26:2755–64.PubMed
55.
Full KM, Lutsey PL, Norby FL, Alonso A, Soliman EZ, Rooney MR, Chen LY. Association between excessive daytime sleepiness and measures of supraventricular arrhythmia burden: evidence from the Atherosclerosis Risk in Communities (ARIC) study. Sleep Breath. 2020;24:1223–7.PubMedPubMedCentralCrossRef
Metadata
Title
Increased susceptibility to new-onset atrial fibrillation in diabetic women with poor sleep behaviour traits: findings from the prospective cohort study in the UK Biobank
Authors
Siwei Chen
Zhou Liu
Shaohua Yan
Zhongyan Du
Wenke Cheng
Publication date
01-12-2024
Publisher
BioMed Central
Published in
Diabetology & Metabolic Syndrome / Issue 1/2024
Electronic ISSN: 1758-5996
DOI
https://doi.org/10.1186/s13098-024-01292-1

Other articles of this Issue 1/2024

Diabetology & Metabolic Syndrome 1/2024 Go to the issue

Research

Sacubitril/valsartan ameliorates tubulointerstitial fibrosis by restoring mitochondrial homeostasis in diabetic kidney disease

Research

Liver indicators affecting the relationship between BMI and hypertension in type 2 diabetes: a mediation analysis

Research

Toe brachial index and not ankle brachial index is appropriate in initial evaluation of peripheral arterial disease in type 2 diabetes

Review

2024 UPDATE: the Brazilian Diabetes Society position on the management of metabolic dysfunction-associated steatotic liver disease (MASLD) in people with prediabetes or type 2 diabetes

Research

Connections between body composition and dysregulation of islet α- and β-cells in type 2 diabetes

Correction

Correction: Toe brachial index and not ankle brachial index is appropriate in initial evaluation of peripheral arterial disease in type 2 diabetes
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits